Science Raises $400 Million for Sight-Restoring Implant
The financing backs PRIMA’s European rollout and a planned US launch that still requires FDA approval.
By: The Defiant •
Technology
The financing backs PRIMA’s European rollout and a planned US launch that still requires FDA approval.
Loading this article…






